- Home
- GLMD vs ISPC Comparison
GLMD vs ISPC Comparison
Compare GLMD & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- ISPC
- Stock Information
- Founded
- GLMD 2000
- ISPC 2009
- Country
- GLMD Israel
- ISPC United States
- Employees
- GLMD N/A
- ISPC N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- GLMD Health Care
- ISPC Health Care
- Exchange
- GLMD Nasdaq
- ISPC Nasdaq
- Market Cap
- GLMD 3.0M
- ISPC 3.1M
- IPO Year
- GLMD 2014
- ISPC 2021
- Fundamental
- Price
- GLMD $1.83
- ISPC $0.99
- Analyst Decision
- GLMD Hold
- ISPC
- Analyst Count
- GLMD 1
- ISPC 0
- Target Price
- GLMD N/A
- ISPC N/A
- AVG Volume (30 Days)
- GLMD 353.4K
- ISPC 44.7K
- Earning Date
- GLMD 05-22-2025
- ISPC 08-05-2025
- Dividend Yield
- GLMD N/A
- ISPC N/A
- EPS Growth
- GLMD N/A
- ISPC N/A
- EPS
- GLMD N/A
- ISPC N/A
- Revenue
- GLMD N/A
- ISPC $8,058,631.00
- Revenue This Year
- GLMD N/A
- ISPC $35.93
- Revenue Next Year
- GLMD N/A
- ISPC N/A
- P/E Ratio
- GLMD N/A
- ISPC N/A
- Revenue Growth
- GLMD N/A
- ISPC N/A
- 52 Week Low
- GLMD $1.15
- ISPC $0.86
- 52 Week High
- GLMD $23.80
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- GLMD 60.37
- ISPC 43.82
- Support Level
- GLMD $1.74
- ISPC $0.90
- Resistance Level
- GLMD $1.91
- ISPC $1.03
- Average True Range (ATR)
- GLMD 0.12
- ISPC 0.07
- MACD
- GLMD -0.00
- ISPC -0.00
- Stochastic Oscillator
- GLMD 71.95
- ISPC 36.03
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.